View in EDS HTML Full Text PDF Full Text

Efficacy of Second-Line Lenvatinib After Atezolizumab–Bevacizumab and Durvalumab–Tremelimumab in Unresectable Hepatocellular Carcinoma: Association with Prior Immunotherapy Response.

Saved in:
Bibliographic Details
Title: Efficacy of Second-Line Lenvatinib After Atezolizumab–Bevacizumab and Durvalumab–Tremelimumab in Unresectable Hepatocellular Carcinoma: Association with Prior Immunotherapy Response.
Authors: Kuzuya, Teiji1 (AUTHOR) teiji.kuzuya@fujita-hu.ac.jp, Muto, Hisanori1,2 (AUTHOR), Tachi, Yoshihiko1,3 (AUTHOR), Komura, Gakushi1 (AUTHOR), Nakano, Takuji1,2 (AUTHOR), Tanaka, Hiroyuki1,3 (AUTHOR), Nakaoka, Kazunori1 (AUTHOR), Funasaka, Kohei1 (AUTHOR), Nagasaka, Mitsuo1 (AUTHOR), Miyahara, Ryoji1 (AUTHOR), Ohno, Eizaburo1 (AUTHOR)
Source: Cancers. Jul2026, Vol. 18 Issue 13, p2095. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 195444787
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of Second-Line Lenvatinib After Atezolizumab–Bevacizumab and Durvalumab–Tremelimumab in Unresectable Hepatocellular Carcinoma: Association with Prior Immunotherapy Response.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Kuzuya%2C+Teiji%22">Kuzuya, Teiji</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> teiji.kuzuya@fujita-hu.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Muto%2C+Hisanori%22">Muto, Hisanori</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tachi%2C+Yoshihiko%22">Tachi, Yoshihiko</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Komura%2C+Gakushi%22">Komura, Gakushi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nakano%2C+Takuji%22">Nakano, Takuji</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tanaka%2C+Hiroyuki%22">Tanaka, Hiroyuki</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nakaoka%2C+Kazunori%22">Nakaoka, Kazunori</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Funasaka%2C+Kohei%22">Funasaka, Kohei</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nagasaka%2C+Mitsuo%22">Nagasaka, Mitsuo</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Miyahara%2C+Ryoji%22">Miyahara, Ryoji</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ohno%2C+Eizaburo%22">Ohno, Eizaburo</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancers%22">Cancers</searchLink>. Jul2026, Vol. 18 Issue 13, p2095. 17p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=195444787
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers18132095
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 17
        StartPage: 2095
    Titles:
      – TitleFull: Efficacy of Second-Line Lenvatinib After Atezolizumab–Bevacizumab and Durvalumab–Tremelimumab in Unresectable Hepatocellular Carcinoma: Association with Prior Immunotherapy Response.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kuzuya, Teiji
      – PersonEntity:
          Name:
            NameFull: Muto, Hisanori
      – PersonEntity:
          Name:
            NameFull: Tachi, Yoshihiko
      – PersonEntity:
          Name:
            NameFull: Komura, Gakushi
      – PersonEntity:
          Name:
            NameFull: Nakano, Takuji
      – PersonEntity:
          Name:
            NameFull: Tanaka, Hiroyuki
      – PersonEntity:
          Name:
            NameFull: Nakaoka, Kazunori
      – PersonEntity:
          Name:
            NameFull: Funasaka, Kohei
      – PersonEntity:
          Name:
            NameFull: Nagasaka, Mitsuo
      – PersonEntity:
          Name:
            NameFull: Miyahara, Ryoji
      – PersonEntity:
          Name:
            NameFull: Ohno, Eizaburo
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: Jul2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 20726694
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1